Novozymes 1Q 2010: strong performance an
๐
Article
๐
2010
๐
Elsevier Science
โ 63 KB
net sales of โฌ245 M (โฌ209 M for its 1Q 2009) and recurring EBITDA of โฌ38 M (โฌ14 M). Novecare reported significant improvement in profit driven by increased activity (volumes up by 18% year-on-year) across all regions, particularly in Asia. Volumes in the Industrial and the Agrochemical markets enjoy